Date | Title | Description | Category | Author | Source |
22.05.2023 | Directorat... | Directorate Change
Mon, May 2... | - | - | news.cisio... |
17.05.2023 | Tagrisso p... | Tagrisso plus chemo improved P... | - | - | news.cisio... |
09.05.2023 | Director/P... | Director/PDMR Shareholding
Tu... | - | - | news.cisio... |
03.05.2023 | FDA approv... | Older Americans this fall coul... | - | - | cbsnews.co... |
02.05.2023 | Director/P... | Director/PDMR Shareholding
Tu... | - | - | news.cisio... |
02.05.2023 | Total Voti... | Total Voting Rights
Tue, May ... | - | - | news.cisio... |
02.05.2023 | ODAC vote ... | ODAC vote on Lynparza combo in... | - | - | news.cisio... |
28.04.2023 | AstraZenec... | A replacement for a key COVID-... | - | - | cbsnews.co... |
27.04.2023 | Result of ... | Result of AGM
Thu, Apr 27, 20... | - | - | news.cisio... |
27.04.2023 | Board Comm... | Board Committee Changes
Thu, ... | - | - | news.cisio... |
27.04.2023 | 1st Quarte... | 1st Quarter Results
Thu, Apr ... | - | - | news.cisio... |
26.04.2023 | Director D... | Director Declaration
Wed, Apr... | - | - | news.cisio... |
11.04.2023 | Update to ... | Update to arrangements with So... | - | - | news.cisio... |
05.04.2023 | Lynparza +... | Lynparza + Imfinzi met endpoin... | - | - | news.cisio... |
03.04.2023 | Ultomiris ... | Ultomiris recommended for NMOS... | - | - | news.cisio... |
03.04.2023 | Total Voti... | Total Voting Rights
Mon, Apr ... | - | - | news.cisio... |
30.03.2023 | AstraZenec... | AstraZeneca completes KYM agre... | - | - | news.cisio... |
27.03.2023 | Director/P... | Director/PDMR Shareholding
Mo... | - | - | news.cisio... |
22.03.2023 | Notice of ... | Notice of AGM
Wed, Mar 22, 20... | - | - | news.cisio... |
09.03.2023 | Imfinzi im... | Imfinzi improved EFS in resect... | - | - | news.cisio... |
08.03.2023 | Director/P... | Director/PDMR Shareholding
We... | - | - | news.cisio... |
06.03.2023 | Enhertu DE... | Enhertu DESTINY-PanTumor02 sho... | - | - | news.cisio... |
01.03.2023 | The She–Su... | “The outdated system of work h... | - | - | prweb.com/... |
01.03.2023 | Total Voti... | Total Voting Rights
Wed, Mar ... | - | - | news.cisio... |
01.03.2023 | AstraZenec... | AstraZeneca prices a $2.25bn b... | - | - | news.cisio... |
24.02.2023 | AstraZenec... | AstraZeneca acquires CinCor fo... | - | - | news.cisio... |
24.02.2023 | AstraZenec... | AstraZeneca prices a EUR1.5bn ... | - | - | news.cisio... |
24.02.2023 | Director/P... | Director/PDMR Shareholding
Fr... | - | - | news.cisio... |
23.02.2023 | AstraZenec... | AstraZeneca enters agreement w... | - | - | news.cisio... |
22.02.2023 | Filing of ... | Filing of Form 20-F with SEC
... | - | - | news.cisio... |
21.02.2023 | Annual Fin... | Annual Financial Report
Tue, ... | - | - | news.cisio... |
13.02.2023 | Director/P... | Director/PDMR Shareholding
Mo... | - | - | news.cisio... |
01.02.2023 | Total Voti... | Total Voting Rights
Wed, Feb ... | - | - | news.cisio... |
01.02.2023 | Where Big ... | Hormone therapies are well est... | - | - | medcitynew... |
26.01.2023 | Update on ... | Update on Evusheld US EUA
Thu... | - | - | news.cisio... |
16.01.2023 | Acquisitio... | Acquisition of Neogene Therape... | - | - | news.cisio... |
09.01.2023 | AstraZenec... | AstraZeneca acquire CinCor for... | - | - | news.cisio... |
03.01.2023 | Total Voti... | Total Voting Rights
Tue, Jan ... | - | - | news.cisio... |
30.12.2022 | Director/P... | Director/PDMR Shareholding
Fr... | - | - | news.cisio... |
28.12.2022 | Calquence ... | Calquence Japan approval for t... | - | - | news.cisio... |
28.12.2022 | Imfinzi, I... | Imfinzi, Imjudo approved in Ja... | - | - | news.cisio... |
21.12.2022 | Imfinzi ap... | Imfinzi approved in EU for bil... | - | - | news.cisio... |
21.12.2022 | Lynparza a... | Lynparza approved in EU for pr... | - | - | news.cisio... |
19.12.2022 | Enhertu ap... | Enhertu approved in EU for gas... | - | - | news.cisio... |
19.12.2022 | Enhertu re... | Enhertu recommended for EU app... | - | - | news.cisio... |
19.12.2022 | Imfinzi + ... | Imfinzi + Imjudo recommended f... | - | - | news.cisio... |
19.12.2022 | Forxiga CH... | Forxiga CHMP opinion for sympt... | - | - | news.cisio... |
19.12.2022 | Update on ... | Update on Imfinzi PEARL trial
... | - | - | news.cisio... |
15.12.2022 | Update on ... | Update on US review of Lynparz... | - | - | news.cisio... |
08.12.2022 | Capivasert... | Capivasertib PFS in HR-positiv... | - | - | news.cisio... |
05.12.2022 | Digital he... | Vial raised $67M; NextGen Heal... | - | Steven Loe... | vator.tv/n... |
01.12.2022 | Block list... | Block listing Interim Review
... | - | - | news.cisio... |
01.12.2022 | Total Voti... | Total Voting Rights
Thu, Dec ... | - | - | news.cisio... |
30.11.2022 | AstraZenec... | AstraZeneca announces sale of ... | - | - | news.cisio... |
29.11.2022 | AstraZenec... | AstraZeneca to acquire Neogene... | - | - | news.cisio... |
29.11.2022 | AstraZenec... | Cell therapy has broken new th... | - | - | medcitynew... |
24.11.2022 | AstraZenec... | JAKARTA, Indonesia, Nov. 24, 2... | - | - | en.prnasia... |
23.11.2022 | Director/P... | Director/PDMR Shareholding
We... | - | - | news.cisio... |
14.11.2022 | Imfinzi re... | Imfinzi recommended for approv... | - | - | news.cisio... |
14.11.2022 | Enhertu re... | Enhertu recommended for EU app... | - | - | news.cisio... |
14.11.2022 | Lynparza c... | Lynparza combo recommended in ... | - | - | news.cisio... |
13.11.2022 | AstraZenec... | AstraZeneca cancer drug Imjudo... | - | - | medcitynew... |
11.11.2022 | Imfinzi + ... | Imfinzi + Imjudo approved in U... | - | - | news.cisio... |
10.11.2022 | YTD and Q3... | YTD and Q3 2022 Results
Thu, ... | - | - | news.cisio... |
04.11.2022 | Press Rele... | European Commission grants fir... | - | - | einpresswi... |
04.11.2022 | Communiqué... | /EIN News/ -- La Commission eu... | - | - | einpresswi... |
04.11.2022 | Sanofi, As... | Late last year, Sage’s chief m... | - | Amber Tong | endpts.com... |
04.11.2022 | Press Rele... | /EIN News/ -- European Commiss... | - | - | einpresswi... |
04.11.2022 | Beyfortus ... | Beyfortus (nirsevimab) approve... | - | - | news.cisio... |
01.11.2022 | Total Voti... | Total Voting Rights
Tue, Nov ... | - | - | news.cisio... |
28.10.2022 | 創紀醫學集團旗下再心... | BOSTON, MASSACHUSETTS, UNITED ... | - | - | einpresswi... |
27.10.2022 | Medera’s N... | BOSTON, MASSACHUSETTS, UNITED ... | - | - | einpresswi... |
24.10.2022 | AstraZenec... | An AstraZeneca antibody drug i... | - | - | medcitynew... |
04.10.2022 | AstraZenec... | LogicBio’s lead gene-editing t... | - | - | medcitynew... |
21.09.2022 | Tezspire a... | Tezspire approved in the EU fo... | - | - | news.cisio... |
20.09.2022 | Evusheld a... | Evusheld approved in EU for CO... | - | - | news.cisio... |
16.09.2022 | Press Rele... | CHMP recommends approval of Be... | - | - | globenewsw... |
16.09.2022 | Evusheld p... | Evusheld positive CHMP opinion... | - | - | news.cisio... |
16.09.2022 | Danicopan ... | Danicopan Phase III trial met ... | - | - | news.cisio... |
16.09.2022 | Press Rele... | /EIN News/ -- CHMP recommends ... | - | - | einpresswi... |
16.09.2022 | Nirsevimab... | Nirsevimab recommended for app... | - | - | news.cisio... |
05.09.2022 | Imfinzi ap... | Imfinzi approved in US for bil... | - | - | news.cisio... |
05.09.2022 | Forxiga ap... | Forxiga approved in China for ... | - | - | news.cisio... |
01.09.2022 | Total Voti... | Total Voting Rights
Thu, Sep ... | - | - | news.cisio... |
30.08.2022 | Farxiga re... | Farxiga reduced risk of CV dea... | - | - | news.cisio... |
30.08.2022 | Evusheld a... | Evusheld approved for COVID-19... | - | - | news.cisio... |
30.08.2022 | Farxiga sh... | Farxiga shows CV mortality ben... | - | - | news.cisio... |
25.08.2022 | Tagrisso a... | Tagrisso approved in Japan for... | - | - | news.cisio... |
25.08.2022 | Lynparza a... | Lynparza approved in Japan for... | - | - | news.cisio... |
25.08.2022 | Ultomiris ... | Ultomiris approved in Japan fo... | - | - | news.cisio... |
16.08.2022 | FDA grants... | AstraZeneca and Merck’s top-... | - | Aayushi Pr... | endpts.com... |
16.08.2022 | Lynparza g... | Lynparza granted FDA priority ... | - | - | news.cisio... |
15.08.2022 | Enhertu im... | Enhertu improved PFS in mBC in... | - | - | news.cisio... |
12.08.2022 | Enhertu ap... | Enhertu approved in US for HER... | - | - | news.cisio... |
11.08.2022 | Acquisitio... | Acquisition of TeneoTwo comple... | - | - | news.cisio... |
08.08.2022 | Enhertu ap... | Enhertu approved in the US for... | - | - | news.cisio... |
04.08.2022 | Lynparza a... | Lynparza approved in EU for ea... | - | - | news.cisio... |
01.08.2022 | Total Voti... | Total Voting Rights
Mon, Aug ... | - | - | news.cisio... |
01.08.2022 | Director/P... | Director/PDMR Shareholding
Mo... | - | - | news.cisio... |
01.08.2022 | Director/P... | Director/PDMR Shareholding
Mo... | - | - | news.cisio... |
29.07.2022 | Chair succ... | Chair succession
Fri, Jul 29,... | - | - | news.cisio... |